Skip to content

Effect of Oral Nutritional Supplements to Older Patients Discharged With a Rehabilitation Plan

Effect of Oral Nutritional Supplements on Muscle Strength in Older Patients at Nutritional Risk Discharged With a Rehabilitation Plan

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05556876
Acronym
NUTRIMUSCLE
Enrollment
123
Registered
2022-09-27
Start date
2023-12-01
Completion date
2026-03-30
Last updated
2026-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional Risk, Oral Nutritional Supplements, Rehabilitation

Keywords

muscle strenght, quality of life, body composition, protein intake

Brief summary

The purpose of the study is to investigate whether an extra intake of energy and protein in the form of nutritional drinks twice a day for 12 weeks can improve muscle strength, muscle mass, quality of life and the implementation of rehabilitation in elderly patients at nutritional risk who are discharged to municipal rehabilitation

Detailed description

The study is a single-blind randomised study where the subjects will be randomly divided into two groups. A group that must consume nutritional drinks in connection with their rehabilitation and a group that must do nothing extra. Based on a statistical power calculation, we will include a total of 124 patients. In connection with the experiment, different data will be collected three times, in connection with the discharge from the hospital, after 6 weeks via the telephone and after 12 weeks. During a home visit. Here, various questionnaires will have to be answered and data on muscle strength and muscle mass will be collected. Further CRP, vitamin D status and EPA/DHA content in blood will be assessed. In addition, data is collected from the patient's medical record about e.g. readmissions

Interventions

DIETARY_SUPPLEMENTProtein omega-3

An oral supplement with a high content of protein and with essential fatty acids

Sponsors

Herlev and Gentofte Hospital
Lead SponsorOTHER
Nutricia, Inc.
CollaboratorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

two set of files

Intervention model description

A single-blinded randomised study

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Men and women aged ≥ 65 years old * Independent stand function * Able to speak and understand Danish * At nutritional risk according to NRS-2002 * (Expected to be) discharged with a new rehabilitation plan * Admitted to the medical and orthopaedic departments of Gentofte or Herlev Hospital

Exclusion criteria

* Active cancer * Renal insufficiency (eGFR \< 27 mL/min/1.73m2) * Cognitive impairment (not able to comprehend the purpose of the study/give informed consent) * Terminal disease * Exclusively receiving texture modified food, enteral or parenteral nutrition * Planning to lose weight/go on a special diet * Planned transfer to other hospitals/departments * Pacemaker/other implanted electrical stimulants (due to Bio-Impedance Analysis (BIA) * Taking fish-oil supplements as a medical prescription due to hypertriglyceridemia * Taking fish-oil supplements for other reasons and do not wish to stop this during the study period

Design outcomes

Primary

MeasureTime frameDescription
Leg Muscle strengthchange from baseline to 12 weeks follow-upChair stand

Secondary

MeasureTime frameDescription
Hand grip Muscle strengthchange from baseline to 12 weeks follow-upHand grip strength
Health related quality of lifeChange from baseline to 6 and 12 weeks follow-upEQ5D5L questionnaire with five dimensions and five level of answers. To be converted to an index were -1 is worst and 1 is best health related quality of life
Activities of daily livingChange from baseline to 6 and 12 weeks follow-upFunctional recovery score The eleven-item questionnaire is comprised of three main components: basic activities of daily living (BADL) assessed by four items, instrumental activities of daily living (IADL) assessed by six items, and mobility assessed by one item. Basic activities of daily living comprise 44 percent of the score; instrumental activities of daily living comprise 23 percent, and mobility comprises 33 percent. Complete independence in basic and instrumental activities of daily living and mobility results in a score of 100 percent
energy and protein intakeat 12 weeks follow-up24 hour dietary recall
AppetiteChange from baseline to 12 week follow-upSimplified Nutritional Appetite Questionnaire \[SNAQ. The questionnaire results in a score ranging from 5 to 20, where 5 is lowest appetite
Muscle massChange from baseline to 12 week follow-upCalf circumference assessment of muscle mass
FrailtyChange from baseline to 12 weeks follow-upThe "FRAIL" Questionnaire includes questions concerning Fatigue, Resistance (capability of stair climbing),Aerobic( walking distance), Illnesses (multi morbidity), and Loss of weight. Physical frailty, pre-frailty and non-frailty is defined as having 3 or greater; 1 or 2 or no factors respectively
initiation and completion of rehabilitationat 12 week follow-upquestionnaire were participants can document their attendance to exercise rehabilitation and reasons for not attending.
compliance to oral nutritional supplementsat 12 weeks follow-upa diary were participants can register their intake of supplements and eventual side effects. A compliance of 100% is aimed for as optimal
readmissions30 days and 38 weeks after dischargenumber, length and percentage of readmissions after discharge will be calculated
mortality30 days and 38 weeks after dischargenumber and percentage of mortality after discharge will be calculated
inflammationchange from baseline to 12 weeks follow-upblood measurements of CRP and omega-3 fatty acids
vitamin D statuschange from baseline to 12 weeks follow-upblood measurements of vitamin D
Hydration statusChange from Baseline to 12 weeks follow upBlood measurements and calculation of serum osmolarity

Countries

Denmark

Contacts

STUDY_DIRECTORTina Munk, PhD

Herlev and Gentofte Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 8, 2026